Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on November 3, 2023. The filing addresses "Other Events" related to the resale of specific classes of the Company's securities under a previously filed Registration Statement on Form S-3ASR.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on securities registration events rather than financial performance data.
Material Changes and Events
On November 3, 2023, the Company filed two prospectus supplements regarding the resale of shares by selling stockholders:
- Acquisition Shares: Resale of up to 8,474,576 shares of Class A Common Stock. These shares were originally issued on January 20, 2023, to Magellan Health, Inc. as consideration for the acquisition of National Imaging Health, Inc. and certain assets (the "NIA Acquisition").
- Conversion Shares: Resale of up to 4,375,000 shares of Class A Common Stock. These shares are issuable upon the conversion of 175,000 shares of Cumulative Series A Convertible Preferred Stock, which were also issued in connection with the NIA Acquisition.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosures associated with the resale of securities. The primary purpose is to facilitate the resale of shares by selling stockholders named in the respective prospectus supplements.
Key Facts for Investor Verification
- Verify the identity of the selling stockholders named in the Acquisition Share and Conversion Share Prospectus Supplements.
- Confirm the total number of shares available for resale (8,474,576 Acquisition Shares and 4,375,000 Conversion Shares).
- Review the underlying Registration Statement (No. 333-266495) filed on August 3, 2022, for full terms of the securities.
- Note that the shares were issued as consideration for the NIA Acquisition from Magellan Health, Inc.